BofA raises Johnson & Johnson price target to $263 from $254
JNJ•Related News
JBDI Holdings sales director Kelvin Lim files initial beneficial ownership statement
JBDI•
NASDAQ trade halt continues for PLTS, reason not available
PLTS•
Bristol-Myers Squibb price target cut to $66 from $67 by BofA Global Research
BMY•
Nasdaq pauses trading in GIBO due to volatility at 10:44 a.m.
GIBO•
Nasdaq trade halt continues for PLTS, reason unavailable at 10:05 a.m.
PLTS•